Cel-Sci Corp

Research Cel-Sci Corp (CVM) on Bullrun: market cap USD 9.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCVM
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 9.17M
• Financial periodFY2025
• Net income-USD 25.41M
• Free cash flow-USD 17.16M

Valuation Snapshot

latest market cap is USD 9.17M.

About Cel-Sci Corp

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers.

Frequently asked questions

What is Cel-Sci Corp's market cap?

Cel-Sci Corp's market capitalization is USD 9.17M.

What does Cel-Sci Corp do?

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.